Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
H. Lee Moffitt Cancer Center & Research Institute, working in partnership with the University of South Florida (USF), has discovered a new use for an old, previously discredited anti-cancer drug that could add another weapon in the arsenal against several cancers, including tumors of the breast, ovary, colon, skin and prostate. The compound, tricirbine, was tested at various cancer cen...Wireless carriers mislead consumers about USF reform
customers with access to high-tech communication services. Beginning with traditional wireline telephone service and now with high-speed broadband Internet service in...Morepan to file new drug applications with the USFDA
Domestic pharma major Morepen Labs is planning to file its nine abbreviated new drug applications (ANDA) with the US FDA by the year 2003. The company would file its first two ANDAs - Loratadine (anthistatminic drug) and Atorvastain Calcium (anti-cholesterol) - by the end of 2002. Loratadine is the third-largest selling drug in the world. Currently, Morepen’s ANDAs pipeline has Loratad...Ranbaxy Gets USFDA Approval For Doxycycline Tablets
Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.// The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg. Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms inclu...Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market. // The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange. The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it...Lupin Gets USFDA Approval For Quinapril Tablets
Pharmaceutical company Lupin Ltd today said it has recieved the final approval from USFDA to market its Abbreviated New Drug Application (ANDA) of hypertension medicine Quinapril in US. // The company informed the Bombay Stock Exchange that the approval is for the multiple dosages of strengths 5 mg, 10 mg, 20 mg and 40 mg. Quinapril is a AB-rated generic equivalent of Pfiz...Ranbaxy Gets USFDA Nod For Simvastatin
Pharma major Ranbaxy Laboratories Ltd has received approval from the USFDA for manufacturing and marketing cholesterol-lowering Simvastatin Tablets in the US market. // The company said it has received the approval for marketing the drug in strengths of 80mg with 180 day exclusivity. Simvastatin, currently marketed as 'Zocor' in the US, has been found to be bioequivalent b...